| Pharmaceutical active ingredients: |
| Naphazoline HydrochloridePheniramine Maleate |
| Available forms, composition and doses of Miral: |
| Solution; Ophthalmic; Naphazoline Hydrochloride 0.025%; Pheniramine Maleate 0.3% |
| Miral medical category: |
| Human:Ophthalmic decongestants, anesthetics, anti-inflammatoriesVasoconstrictors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| S01GA51 - Naphazoline, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Chile Laboratorios |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Flamergi | Naphazoline Hydrochloride; Pheniramine Maleate | Sanbe Farma |
| Irazol | Naphazoline Hydrochloride; Pheniramine Maleate | Ashford Pharmaceutical Laboratories; Medilife Pharma |
| Isotic Azora | Naphazoline Hydrochloride; Pheniramine Maleate | Fahrenheit |
| Konjunktival | Naphazoline Hydrochloride; Pheniramine Maleate | Alcon |
| Konjunktival Thilo | Naphazoline Hydrochloride; Pheniramine Maleate | Alcon; DKSH; Firma Chun Cheong |
| Mirus | Naphazoline Hydrochloride; Pheniramine Maleate | Alcon |
| Nafazair A | Naphazoline Hydrochloride; Pheniramine Maleate | Bausch and Lomb |
| Nafcon A | Naphazoline Hydrochloride; Pheniramine Maleate | Alcon |
| Naphazole-A | Naphazoline Hydrochloride; Pheniramine Maleate | The Harvard Drug Group |
| Naphazoline Plus | Naphazoline Hydrochloride; Pheniramine Maleate | Parmed Pharmaceuticals |